LU86711A1 - Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa - Google Patents

Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa Download PDF

Info

Publication number
LU86711A1
LU86711A1 LU86711A LU86711A LU86711A1 LU 86711 A1 LU86711 A1 LU 86711A1 LU 86711 A LU86711 A LU 86711A LU 86711 A LU86711 A LU 86711A LU 86711 A1 LU86711 A1 LU 86711A1
Authority
LU
Luxembourg
Prior art keywords
antibody
iats
composition according
fisher
serotypes
Prior art date
Application number
LU86711A
Other languages
English (en)
French (fr)
Inventor
Anthony W Siadak
Mae J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of LU86711A1 publication Critical patent/LU86711A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU86711A 1985-12-10 1986-12-10 Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa LU86711A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US80739485 1985-12-10
US93117986A 1986-11-24 1986-11-24
US93117986 1986-11-24

Publications (1)

Publication Number Publication Date
LU86711A1 true LU86711A1 (fr) 1988-07-14

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86711A LU86711A1 (fr) 1985-12-10 1986-12-10 Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa

Country Status (21)

Country Link
US (4) US5378812A (it)
JP (1) JPH07116237B2 (it)
KR (1) KR910008361B1 (it)
CN (1) CN86108380A (it)
AT (1) AT400441B (it)
BE (1) BE905890A (it)
CH (1) CH677362A5 (it)
DE (1) DE3642095C2 (it)
DK (1) DK594586A (it)
FI (1) FI86377C (it)
FR (1) FR2593826B1 (it)
GB (1) GB2185266B (it)
HU (1) HUT41836A (it)
IE (1) IE59741B1 (it)
IT (1) IT1199735B (it)
LU (1) LU86711A1 (it)
NL (1) NL8603132A (it)
NO (1) NO178718C (it)
NZ (1) NZ218499A (it)
PT (1) PT83894B (it)
SE (1) SE468831B (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
AU591017B2 (en) * 1986-12-15 1989-11-23 Mitsui Toatsu Chemicals Inc. Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
EP0414921A4 (en) * 1989-03-20 1992-03-18 Mitsui Toatsu Chemicals, Inc. Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
AU5675790A (en) * 1989-05-09 1990-11-29 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
JP2005528887A (ja) * 2002-01-31 2005-09-29 エクスプレッシブ コンストラクツ，インコーポレイテッド 微生物の検出方法
US20060292562A1 (en) * 2002-05-29 2006-12-28 Pollard Harvey B Methods of identifying genomic and proteomic biomarkers for cystic fibrosis, arrays comprising the biomarkers and methods of using the arrays
DK1567117T3 (da) 2002-11-26 2012-05-21 Univ Chicago Forebyggelse og behandling af mikrobe-medierede epitelsygdomme
AU2004225575B2 (en) * 2003-01-31 2008-02-21 Ethicon, Inc. Method for detecting escherichia coli
JP4864715B2 (ja) 2003-11-03 2012-02-01 エチコン・インコーポレーテツド 細菌の広域スペクトルの検出に有用な方法、ペプチドおよびバイオセンサー
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
CA2649663C (en) * 2006-05-01 2017-03-14 Bioness Neuromodulation Ltd. Improved functional electrical stimulation systems
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
EP2536759A4 (en) * 2010-02-18 2013-09-18 Meiji Seika Pharma Co Ltd ANTIBODY AGAINST LIPOPOLYSACCHARIDE OF SERO TYPE I OF PSEUDOMONAS AERUGINOSA
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
WO1984004458A1 (en) * 1983-05-06 1984-11-22 Matthew Pollack Monoclonal antibodies reactive with endotoxin core
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
WO1985002685A1 (en) * 1983-12-12 1985-06-20 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
HUT41836A (en) 1987-05-28
JPS62187417A (ja) 1987-08-15
US5628996A (en) 1997-05-13
NO864971D0 (no) 1986-12-10
NO178718C (no) 1996-05-22
US5378812A (en) 1995-01-03
CH677362A5 (it) 1991-05-15
BE905890A (fr) 1987-06-10
NO178718B (no) 1996-02-12
IE59741B1 (en) 1994-03-23
GB2185266B (en) 1990-09-05
AT400441B (de) 1995-12-27
PT83894A (en) 1987-01-01
DK594586A (da) 1987-06-11
NL8603132A (nl) 1987-07-01
FR2593826B1 (fr) 1990-11-16
JPH07116237B2 (ja) 1995-12-13
US5627067A (en) 1997-05-06
FI865027A0 (fi) 1986-12-10
GB8629540D0 (en) 1987-01-21
ATA328286A (de) 1995-05-15
US5662905A (en) 1997-09-02
FI86377B (fi) 1992-05-15
GB2185266A (en) 1987-07-15
SE8605295D0 (sv) 1986-12-10
FR2593826A1 (fr) 1987-08-07
SE468831B (sv) 1993-03-29
PT83894B (pt) 1989-07-31
DK594586D0 (da) 1986-12-10
IE863230L (en) 1987-06-10
CN86108380A (zh) 1987-10-28
FI86377C (fi) 1992-08-25
DE3642095C2 (de) 1998-10-01
KR870005648A (ko) 1987-07-06
DE3642095A1 (de) 1987-07-02
NZ218499A (en) 1990-04-26
KR910008361B1 (ko) 1991-10-12
FI865027A (fi) 1987-06-11
IT1199735B (it) 1988-12-30
IT8622630A0 (it) 1986-12-10
NO864971L (no) 1987-06-11
SE8605295L (sv) 1987-06-11

Similar Documents

Publication Publication Date Title
LU86711A1 (fr) Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa
FI111336B (fi) Menetelmä Staphylococcus epidermidis tyyppi I:n polysakkaridiantigeenin sisältävän rokotteen ja antigeeninvastaisen hyperimmunoglobuliinin valmistamiseksi
JPS61500355A (ja) グラム陰性菌のエンドトキシンに対するモノクロナ−ル抗体
JPH02283294A (ja) ヒトモノクローナル抗体
JP2009227680A (ja) 腸球菌抗原およびワクチン
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
JP2645665B2 (ja) ヒトモノクローナル抗体
EP0695192B1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
EP0119893B1 (fr) Anticorps monoclonaux anti-Légionella, procédé d&#39;obtention et application au dosage de Légionella pneumophila
JP2639422B2 (ja) シュードモナスアエルギノーザ鞭毛に対するモノクローナル抗体
JP4002187B2 (ja) 抗ふけ菌免疫抗体及びその用途
JPH04211393A (ja) ヒトモノクローナル抗体及びそれを有効成分とする緑膿菌感染症治療剤
BE1001844A4 (fr) Anticorps monoclonal humain contre pseudomonas aeruginosa, sa production et son application.
JPS63500035A (ja) プソイドモナス　アエルギノサ　外毒素ａに対する保護用ヒトモノクロ−ナル抗体
JPH0355106B2 (it)